TX:NYSETernium S.A. Analysis
Data as of 2026-05-06 - not real-time
$48.42
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Ternium (TX) is trading at $48.42, well below its DCF fair value of $112.17, suggesting a substantial valuation gap. The price sits above the 20‑day SMA (43.15) and the 50‑day SMA (41.16), while the 200‑day SMA (37.998) remains lower, indicating a strong upward trend. Technical momentum is bullish with a MACD histogram of 0.32 and a bullish signal line, but the RSI of 74 places the stock in overbought territory. Volume is increasing and the stock is approaching its resistance at $49.69, with support anchored at $40.56. Volatility is high at 38% over the past 30 days, though beta is modest at 0.86, reflecting market‑related risk. Recent material news includes a board‑approved reduction in the 2025 dividend payout and a Bank of America upgrade to "Buy," highlighting both dividend sustainability concerns and renewed analyst confidence.
The fundamentals show modest profitability (gross margin 15%, operating margin 4.2%) and a weak ROE of 1.9%, while the payout ratio exceeds 120% and free cash flow is negative, casting doubt on dividend durability. Nonetheless, the forward P/E of 10.2 and a price‑to‑book below 1.0 point to a value‑oriented opportunity. The sector’s cyclical nature and exposure to Latin American markets add geographic and industry risk, but the current "Extreme Greed" sentiment (Fear & Greed Index 90.38) may be inflating short‑term demand. Overall, the stock appears undervalued from a DCF perspective but carries medium‑term execution risks.
The fundamentals show modest profitability (gross margin 15%, operating margin 4.2%) and a weak ROE of 1.9%, while the payout ratio exceeds 120% and free cash flow is negative, casting doubt on dividend durability. Nonetheless, the forward P/E of 10.2 and a price‑to‑book below 1.0 point to a value‑oriented opportunity. The sector’s cyclical nature and exposure to Latin American markets add geographic and industry risk, but the current "Extreme Greed" sentiment (Fear & Greed Index 90.38) may be inflating short‑term demand. Overall, the stock appears undervalued from a DCF perspective but carries medium‑term execution risks.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- RSI in overbought zone
- Proximity to resistance level
- Recent dividend payout reduction
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Significant valuation gap to DCF fair value
- Bullish MACD and SMA alignment
- Analyst upgrade to Buy
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Low price‑to‑book and forward P/E indicating value
- Potential recovery in steel demand in Latin America
- Long‑term upside despite dividend sustainability concerns
Key Metrics & Analysis
Financial Health
Revenue Growth-2.60%
Profit Margin2.72%
P/E Ratio22.0
ROE1.88%
ROA1.88%
Debt/Equity16.14
P/B Ratio0.8
Op. Cash Flow$2.3B
Free Cash Flow$-666893632
Technical Analysis
TrendBullish
RSI74.1
Support$40.56
Resistance$49.69
MA 20$43.15
MA 50$41.16
MA 200$38.00
MACDBullish
VolumeIncreasing
Fear & Greed Index90.38
Valuation
Fair Value$112.17
Target Price$43.46
Upside/Downside-10.24%
GradeUndervalued
TypeValue
Dividend Yield4.99%
Risk Assessment
Beta0.86
Volatility38.18%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.